George Shih, Wei-Jen Shih, Bonnie Mitchell and Primo P Milan
Department of Radiology, Weill Medical College, Cornell University New York, NY, and Nuclear Medicine Service, Pathology Service and Radiology Service, Lexington VA Medical Center, and Department of Diagnostic Radiology and Department of Pathology, College of Medicine, University of Kentucky, Lexington, Kentucky, U.S.A.
F-18 Fluorodeoxyglucose Positron Emission Tomography imaging (F-18 FDG PET) detects malignancies depending on the uptake profile of glycolysis of tumors; however, the role of FDG PET is limited in the evaluation of primary renal malignancy because of low FDG uptake by renal cell carcinoma and also because normal urinary excretion of FDG seen in the images. A patient with renal cell carcinoma whose FDG PET imaging study incidentally shows a photon-deficient mass in the upper pole of the right kidney is present here. The diagnosis is also validated by the histopathological findings of tumor necrosis, hemorrhage, and scars.
PDF (1.63 MB PDF FORMAT)
RIS citation (ENDNOTE, REFERENCE MANAGER, PROCITE, REFWORKS)
BibTex citation (BIBDESK, LATEX)
I found Clinical Medicine Insights: Case Reports very, very user friendly. The entire process is easy and straightforward. The corresponding author is kept updated on the progress at every point. I am pleased to send this endorsement.
All authors are surveyed after their articles are published. Authors are asked to rate their experience in a variety of areas, and their responses help us to monitor our performance. Presented here are their responses in some key areas. No 'poor' or 'very poor' responses were received; these are represented in the 'other' category.See Our Results
Copyright © 2014 Libertas Academica Ltd (except open access articles and accompanying metadata and supplementary files.)